FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis
This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.
$0 Copay Program Effectively Improved Glycemic Control | ADA 2025
Researchers explored the impact of a $0 copay program on hemoglobin A1c levels in patients with type 2 diabetes who were also insured by Blue Cross and Blue Shield of Louisiana.
Obesity-Related Mortality Rose After COVID-19 Pandemic | ADA 2025
In a retrospective study of obesity-related mortality, researchers explored US death trends before, during, and after the COVID-19 pandemic.
Pharmacist Outreach Can Help Reduce Hypoglycemia Risk | ADA 2025
Data presented at ADA 2025 showed patients who received outreach from a clinical pharmacist were more likely to be prescribed safer diabetes regimens.
Telemedicine With GLP-1 Behavior Program Shows Significant Declines in Weight, Blood Pressure | ADA 2025
In a real-world, 6-month analysis, glucagon-like peptide-1 programs with obesity telemedicine behavioral programs resulted in benefits to weight loss and blood pressure.
Equipping Pharmacists for Evidence-Based Abortion Medication Access
Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, discusses how pharmacists can support patient counseling and education around medication abortion.
Q&A: PBM Unbundling, New Pricing Models Create More Transparency
Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss how the role of PBMs in plan design is evolving.
Younger Adults Disproportionately Not Treated for Cardiometabolic Risk Factors | ADA 2025
When compared with adults 45 years and older, those 18 to 44 years are less likely to receive treatment or achieve target goals for cardiometabolic risk factors.
Flexible Dosing Medications to Help Your Pharmacy Thrive
At the Total Pharmacy Solutions Summit Summer 2025 event, Stephanie Zimmerman, Tom Napolitano, and Luke Gunderson discussed the benefits of Real Value RX.
Pharmacists Play Key Role in Navigating Vaccine Misinformation and Disinformation
Kevin Cleveland, PharmD, discusses how pharmacists are uniquely positioned to provide immediate, direct interactions with patients, making them vital in addressing vaccine misinformation.
CGM Usage Improves Glycemic, Psychosocial Outcomes for Type 1 Diabetes | ADA 2025
Investigators assessed continuous glucose monitoring with behavioral intervention for patients with type 1 diabetes.
Pharmacist Outreach Reduces Therapeutic Inertia in T2D | ADA 2025
Data presented at ADA’s 85th Scientific Sessions showed patients who received physician education with clinical pharmacist outreach had significantly better A1c levels at 6 months compared to usual care.
Expanding Revenue Streams in Independent Pharmacy: Strategies for Today and the Future
Tara Pfund, PharmD, chief strategy officer with the Cascadia Pharmacy Group, discusses a variety of ways community pharmacists can expand services and support clinical reimbursement.
Pharmacist-Led Diabetes Coaching Improved Glycemic Control, Reduced Expenses | ADA 2025
Abstract researchers explored whether or not a pharmacist could serve as the lead of a diabetes coaching program, aiming to reduce medical expenditures and A1C levels for at-risk patients.
Turning Reconciliation into a Revenue Growth Engine
Heidi Polek, RPh, EMBA, discusses how pharmacies must adopt strategic approaches to maintain financial health and continue providing patient care.
Unlocking Pharmacy Value: A Guide to Payer Program Engagement
Emily Endres, BSPS, and Todd Sega, PharmD, MBA, discuss pressures that pharmacies are currently facing, including reimbursements, competition, and patient needs.
Q&A: Supporting Pharmacy Technicians Through Daily Recognition
Taylor Watterson, PharmD, PhD, discusses several different ways pharmacy technician contributions can be better recognized and appreciated.
Pharmacists Play Key Role in Expanding Access to Medication Abortion
Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, discusses how pharmacist involvement in medication abortion can improve reproductive health care access.
Bridging Gaps, Building Connections: NCPDP’s New Vision for the Future of Pharmacy
John Hill, MBAHCM, and Pooja Babbrah, MBA, from the National Council for Prescription Drug Programs, discuss their organization’s strategic plan for advancing the pharmacy profession.
Conference Coverage Recap: American Pharmacists Association Annual Meeting and Exposition 2025
Check out our coverage from the American Pharmacists Association Annual Meeting and Exposition 2025!
How Drug Benefit Design Trends Are Expected to Impact Pharmacists
Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss the 2025 Trends in Drug Benefit Design Report and how it will impact pharmacists.
Pharmacist Discusses Concerns Over Immunization Changes, Public Trust
Laura Knockel, PharmD, BCACP, expresses concerns about how vaccine recommendations are being communicated, noting a shift away from traditional transparent discussions to less formal channels like social media.
Pharmacist Discusses Vaccine Guidance Uncertainty Following ACIP Removal
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, highlights the critical role pharmacists play in navigating vaccine recommendations and supporting patient understanding.
Pharmacist Discusses Proactive Approach to Vaccine Recommendations, Patient Trust
Deanna Tran, PharmD, BCACP, FAPhA, emphasizes community outreach, especially in areas with high vaccine hesitancy, as a crucial strategy for maintaining public trust in vaccination programs.
Pharmacists Successfully Integrate with Multi-Professional Health Care Teams
Researchers explored pharmacists’ ability to collaborate with other health care professionals in single-disciplinary outpatient practice environments.
Q&A: Prioritizing Pharmacy Technician Well-Being
Taylor Watterson, PharmD, PhD, discusses the primary contributors to stress or frustration among pharmacy technicians and how to fix them.
Progress in Dermatology Paves the Way for Vaccine Development
Researchers reviewed current understandings of the role vaccines play in dermatology, what gaps persist, and what future research is necessary.
FDA Approves Dupilumab for Treatment of Bullous Pemphigoid
Bullous pemphigoid is a rare skin condition that causes large blisters filled with fluids that typically occur near skin creases, such as the upper thighs and armpits.
ACIP Panel Removal Sparks Concerns, Pharmacists Warn of More Vaccine Distrust
Pharmacists stress that rebuilding trust is challenging and requires careful, empathetic communication.
SDOH Crucial in Introducing Concept of Social Dermatology
Researchers conducted a narrative review to explore the possibility of integrating social perspectives and aspects into dermatological care and research.